Myomo (MYO) Income from Non-Controlling Interests (2019)
Myomo's (MYO) quarterly Income from Non-Controlling Interests came in at -$2.8 million in Q4 2019, up 0.95% on a QoQ basis from -$2.8 million in Q3 2019.
Myomo (MYO) Income from Non-Controlling Interests (2019) Analysis & Trends
Myomo (MYO) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$2.8 million in Q4 2019.
- Quarterly Income from Non-Controlling Interests changed N/A year-over-year to -$2.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$11.5 million (changed N/A YoY) and the FY2019 annual result came in at -$11.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests improved to -$2.8 million in Q4 2019, from -$2.8 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$2.6 million in Q2 2019 to a low of -$3.4 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 900,000.00 |
| 10 | Myomo | 72.95 Mn | 53.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -2.76 Mn |
| Sep 30, 2019 | -2.79 Mn |
| Jun 30, 2019 | -2.57 Mn |
| Mar 31, 2019 | -3.40 Mn |